Targeting microglial HK2 to treat traumatic brain injury and prevent progression to Alzheimer's-like dementia
A novel therapeutic approach targeting hexokinase 2 (HK2), a glycolytic enzyme that drives chronic microglial inflammation, to limit secondary brain injury after traumatic brain injury (TBI) and reduce the risk of subseq...